APYXNASDAQHealthcare · Medical - Devices

Apyx Medical Corporation

$3.83-2.66%($-0.10)

TickerSpark Score

65/100

Solid

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APYX research report →

52-Week Range79% of range

Low $1.38

Current $3.83

High $4.50

Companywww.apyxmedical.com

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures.

CEO: Charles D. Goodwin
IPO: 2019
Employees: 220
HQ: Clearwater, FL, US

Price Chart

+157.55% · this period

Valuation

Market Cap: $160.59M
P/E: -17.63
P/S: 2.87
P/B: 12.60
EV/EBITDA: -56.81
Div Yield: 0.00%

Profitability

Gross Margin: 32.27%
Op Margin: -7.70%
Net Margin: -16.40%
ROE: -90.62%
ROIC: -7.97%

Growth & Income

Revenue: $52.84M · 9.86%
Net Income: $-11,211,000 · 52.22%
EPS: $-0.27 · 59.09%
Op Income: $-6,446,000
FCF YoY: 51.44%

Performance & Tape

52W High: $4.50
52W Low: $1.38
50D MA: $3.71
200D MA: $3.31
Beta: 1.35
Avg Volume: 166.04K

Get TickerSpark's AI analysis on APYX

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Mar 15, 26	CITRONOWICZ MOSHE	officer: Senior Vice President	other	37,000	$66.60K
Mar 15, 26	CITRONOWICZ MOSHE	officer: Senior Vice President	other	37,000	$66.60K
Jan 27, 26	Roman Shawn David	officer: Chief Operating Officer	other	12,000	$21.60K
Jan 27, 26	Roman Shawn David	officer: Chief Operating Officer	other	12,000	$21.60K
May 15, 25	HILL MATTHEW C	officer: Chief Financial Officer	other	100,000	$148.00K
May 15, 25	CITRONOWICZ MOSHE	officer: Sr. V.P. of Operations	other	36,000	$53.28K
May 15, 25	Waldman Lawrence	director	other	30,000	$44.40K
May 15, 25	Baylor-Henry Minnie	director	other	59,000	$87.32K
May 15, 25	Vizirgianakis Stavros G.	director	other	128,000	$189.44K
May 15, 25	Goodwin Charles D. II	director, officer: Chief Executive Officer	other	193,000	$285.64K

Our APYX Coverage

View all →

ipo_article

Conexeu Sciences Inc. IPO: What to Know Before It Lists

Conexeu Sciences Inc. (NASDAQ: CNXU) is expected to list on 2026-05-21, with the price range not yet disclosed. The setup is a preclinical regenerative medicine story with no FDA-cleared product yet, so shareholders should watch for pricing, dilution, and how the market values the pipeline risk.

May 20, 2026